BAM
LIVE

Serial Number

88428843

Owner

SYNEOS HEALTH, LLC

Attorney

Michael A. Geller

First Use Date

Jan 7, 2019

Filing Date

May 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BAM Trademark

Serial Number: 88428843 • Registration: 6161365

BAM is a trademark filed by SYNEOS HEALTH, LLC on May 14, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SYNEOS HEALTH, LLC (17 trademarks)

1030 SYNC STREET
MORRISVILLE, NC 27560

Entity Type: 16

Trademark Details

Filing Date

May 14, 2019

Registration Date

September 29, 2020

First Use Anywhere

January 7, 2019

First Use in Commerce

January 7, 2019

Published for Opposition

April 14, 2020

Goods & Services

Education services, namely, providing non-downloadable webinars, providing live workshops, providing seminars through on-line non-downloadable videos, providing on-line non-downloadable electronic publications in the nature of articles and white papers, and providing non-downloadable podcasts, all the foregoing in the field of pharmaceutical sales; training services in the field of pharmaceutical sales; providing on-line non-downloadable electronic newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services, namely, providing courses offered through on-line non-downloadable videos, non-downloadable webinars, live workshops, providing online non-downloadable electronic publications in the nature of articles and white papers, and providing non-downloadable podcasts, all the foregoing in the field of clinical trials

Strategic business consulting, information and data collection, namely, compiling and analyzing data and information for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; market analysis and research services; personnel recruitment and placement; recruitment advertising services, namely, advertising clinical trials for the purpose of recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting pharmaceutical and biotechnology companies with preparing and filing applications for new drugs with governmental regulatory bodies; promoting the exchange of health information within the pharmaceutical, biotechnology and life sciences communities to promote patient adherence within the field of pharmaceutical, biotechnology and life sciences clinical trials; extended clinical research services for others, namely, computerized data management of clinical trials

Providing medical information to physicians, other health care professionals and medical patients; providing health information regarding the medications and health care products of others through e-mail alerts and push notifications, namely, providing information concerning product discontinuations; providing health information concerning new formulations of medications and health care products of others through e-mail alerts and push notifications, namely, providing information in the field of pharmaceutical products development; providing health information concerning bottle changes of medications and health care products of others through e-mail alerts and push notifications, namely, providing information in the field of bottle product design, and seasonal information in the nature of reports on pharmaceutical products development

Medical and scientific data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical product clinical testing; extended clinical research services for others for medical purposes, namely, biostatistical analysis for scientific research purposes, preclinical research in the field of pharmaceuticals, biotechnology, and medical sciences, development evaluation, namely, clinical feasibility assessment of protocols and patient recruitment strategies, repairing flawed clinical trials and dossiers, namely, medical and scientific research in the nature of conducting clinical trials for others, and strategic clinical research portfolio management, namely, consulting services for others in the project management of clinical research; extended clinical research services for others in the field of pharmaceuticals, biotechnology, and life sciences, namely, biostatistical analysis for scientific research purposes; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 29, 2025 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 4, 2023 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 15, 2023 ASCK
REGISTERED-PRINCIPAL REGISTER
Sep 29, 2020 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 23, 2020 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
May 14, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 3, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 3, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 3, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 3, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2019 NWOS
NEW APPLICATION ENTERED
May 17, 2019 NWAP